American Journal of Obstetrics & Gynecology
Volume 195, Issue 1 , Pages 149-153 , July 2006

Cessation of asthma medication in early pregnancy

  • Rachel Enriquez, PhD

      Affiliations

    • Departments of Medicine
    • Divisions of Allergy, Pulmonary, and Critical Care Medicine
    • ,
  • Pingsheng Wu, PhD

      Affiliations

    • Departments of Medicine
    • Divisions of Allergy, Pulmonary, and Critical Care Medicine
    • ,
  • Marie R. Griffin, MD, MPH

      Affiliations

    • Departments of Medicine
    • Preventive Medicine
    • General Internal Medicine
    • Center for Education and Research on Therapeutics, Vanderbilt University School of Medicine
    • Mid-South Geriatric Research Education and Clinical Center and Clinical Research Center of Excellence, Veterans Affairs Tennessee Valley Health Care System, Nashville, TN
    • ,
  • Tebeb Gebretsadik, MPH

      Affiliations

    • Biostatistics
    • ,
  • Ayumi Shintani, MPH, PhD

      Affiliations

    • Biostatistics
    • ,
  • Ed Mitchel, MS

      Affiliations

    • Preventive Medicine
    • ,
  • Kecia N. Carroll, MD, MPH

      Affiliations

    • Pediatrics
    • ,
  • Tina V. Hartert, MD, MPH

      Affiliations

    • Departments of Medicine
    • Divisions of Allergy, Pulmonary, and Critical Care Medicine
    • Corresponding Author InformationReprint requests: Tina V. Hartert, MD, MPH, Center for Lung Research, Center for Health Services Research, T-1218 MCN, Vanderbilt University School of Medicine, Nashville, TN 37232-2650.

Received 3 October 2005 ,Revised 6 January 2006 ,Accepted 14 January 2006.

  • Image Result

    Asthma medication utilization by week of pregnancy from 20 weeks prior to LMP to last full week of pregnancy or 40 weeks' gestation. The bar on the right margin is standardized to a 1% change to facil

    Asthma medication utilization by week of pregnancy from 20 weeks prior to LMP to last full week of pregnancy or 40 weeks' gestation. The bar on the right margin is standardized to a 1% change to facilitate comparisons. A, Prevalence of inhaled anti-inflammatory use by week. B, Prevalence of short-acting beta-agonist use by week. C, Prevalence of rescue (oral) corticosteroid use by week.

 Supported in part by research grants UO1 HL 72471, MO1 RR00095, and KO8 AI01582, Agency for Healthcare Research and Quality, Centers for Education and Research Grant U18-HS10384, Geriatric Research Education and Clinical Center, Department of Veterans Affairs, and the Food and Drug Administration FD-U-000073.

PII: S0002-9378(06)00105-0

doi: 10.1016/j.ajog.2006.01.065

American Journal of Obstetrics & Gynecology
Volume 195, Issue 1 , Pages 149-153 , July 2006

Article Tools

* Image Usage & Resolution